Question to the Department of Health and Social Care:

To ask His Majesty's Government whether they will seek the advice of the Joint Committee on Vaccination and Immunisation (JCVI) on coronavirus immunisation treatment using prophylactic antibodies.

The Joint Committee on Vaccination and Immunisation (JCVI) is an independent expert advisory committee which provides advice to Government on immunisation. The JCVI’s remit is focused on vaccination, rather than antibody treatments and prophylaxis, therefore there are no plans to commission such advice.

The multi-agency RAPID C-19 was established in 2020 to ensure treatments for COVID-19 are made safely available for National Health Service patients as soon as possible. RAPID C-19 has the relevant expertise in the range of therapeutic options available for COVID-19 treatment and prevention. It also draws on relevant expertise, including an NHS expert working group and the Prophylaxis Oversight Group.